Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)

NCT07220629 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: NT-0796
DRUG: Placebo

Sponsor

NodThera Limited